Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Cross

Showing results (141-150 of 161) with videos related to

Pageof 17
Sort By:
Annals of Hematology|September 16, 2021
Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trialsThomas Heinicke, Rainer Krahl, Christoph Kahl, et al.
The Journal of Arthroplasty|October 24, 2018
Hip and Knee Section, Prevention, Prosthesis Factors: Proceedings of International Consensus on Orthopedic InfectionsCraig A Aboltins, Valentin Antoci, Sanjib Bhattacharyya, et al.
Annals of Hematology|July 7, 2021
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trialsThomas Heinicke, Rainer Krahl, Christoph Kahl, et al.
Cell Host & Microbe|August 30, 2024
Metabolic immaturity and breastmilk bile acid metabolites are central determinants of heightened newborn vulnerability to norovirus diarrheaAmy M Peiper, Joyce Morales Aparicio, Zhengzheng Hu, et al.
Science Translational Medicine|March 1, 2023
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in <i>SF3B1</i>-mutated myelodysplasiaSyed A Mian, Céline Philippe, Eleni Maniati, et al.
Transfusion|July 29, 2025
Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cellsVladan Vučinić, Theresa Tumewu, Mandy Brückner, et al.
Blood|May 27, 2026
Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programsMariam Hakobyan, Jens Langstein, María José Ramos Medina, et al.
Toxicology and Applied Pharmacology|June 5, 2013
Safety pharmacology--current and emerging conceptsJunnat Hamdam, Swaminathan Sethu, Trevor Smith, et al.
Nature Immunology|June 29, 2026
Inflammatory immune modulators of AML lung infiltration and respiratory failureVarvara Paraskevopoulou, Ziyan Lin, Marta Casado-Pelaez, et al.
Science Advances|March 27, 2024
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in <i>KEAP1</i> mutant lung cancerRay Pillai, Sarah E LeBoeuf, Yuan Hao, et al.
Pageof 17

Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
Annals of Hematology|September 16, 2021
Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trialsThomas Heinicke, Rainer Krahl, Christoph Kahl, et al.
The Journal of Arthroplasty|October 24, 2018
Hip and Knee Section, Prevention, Prosthesis Factors: Proceedings of International Consensus on Orthopedic InfectionsCraig A Aboltins, Valentin Antoci, Sanjib Bhattacharyya, et al.
Annals of Hematology|July 7, 2021
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trialsThomas Heinicke, Rainer Krahl, Christoph Kahl, et al.
Cell Host & Microbe|August 30, 2024
Metabolic immaturity and breastmilk bile acid metabolites are central determinants of heightened newborn vulnerability to norovirus diarrheaAmy M Peiper, Joyce Morales Aparicio, Zhengzheng Hu, et al.
Science Translational Medicine|March 1, 2023
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in <i>SF3B1</i>-mutated myelodysplasiaSyed A Mian, Céline Philippe, Eleni Maniati, et al.
Transfusion|July 29, 2025
Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cellsVladan Vučinić, Theresa Tumewu, Mandy Brückner, et al.
Blood|May 27, 2026
Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programsMariam Hakobyan, Jens Langstein, María José Ramos Medina, et al.
Toxicology and Applied Pharmacology|June 5, 2013
Safety pharmacology--current and emerging conceptsJunnat Hamdam, Swaminathan Sethu, Trevor Smith, et al.
Nature Immunology|June 29, 2026
Inflammatory immune modulators of AML lung infiltration and respiratory failureVarvara Paraskevopoulou, Ziyan Lin, Marta Casado-Pelaez, et al.
Science Advances|March 27, 2024
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in <i>KEAP1</i> mutant lung cancerRay Pillai, Sarah E LeBoeuf, Yuan Hao, et al.
Pageof 17